期刊文献+

去乙酰酶抑制剂N-(2-氨苯基)-4-[N-(吡啶-3-甲氧羰基)氨甲基]苯甲酰胺的合成 被引量:1

Synthesis of N-(2-Aminophenyl)-4-[N-(Pyridin-3-ylmethoxycarbonyl)-Aminomethyl]Benzamide as Histone Deacetylase In hibitors
下载PDF
导出
摘要 以3 羟甲基吡啶为起始原料,采用碳酰二咪唑(CDI)法在0~10℃下搅拌反应,合成中间体4 [N (吡啶 3 甲氧羰基)氨甲基]苯甲酸(Ⅰ),收率为83 9%;然后与氯甲酸乙酯及三乙胺在0~10℃下搅拌反应,制得酸酐活性中间体(Ⅱ);它不经分离直接与邻苯二胺在室温条件下反应10h即得目标产物:N (2 氨苯基) 4 [N (吡啶 3 甲氧羰基)氨甲基]苯甲酰胺,经硅胶柱层析提纯后,收率为45 0%,总收率为37 8%,合成具有一定绿色化学特性;经质谱、核磁和红外等谱学方法鉴定了目标分子结构。 The intermediate 4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl] benzoic acid(Ⅰ) was prepared from 3-hydroxymethylpyridine by using CDI method at 0-10 ℃ in 83.9% yield.Ⅰwas converted to the active acid anhydride(Ⅱ) by treatment with ethyl chloroformate and triethylamine at 0-5 ℃,and then without further separation Ⅱ reacted with o-phenylenediamine for 10 h at room temperature to give the title compound which was separated by silica gel column chromatography in 45.0% yield.Structural analysis of N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl] benzamide was done by mass spectrometry,nuclear magnetic resonance and infrared spectroscopy.
出处 《精细化工》 EI CAS CSCD 北大核心 2003年第5期285-287,共3页 Fine Chemicals
基金 国家教委霍英东基金资助 国家"春晖计划"教育部启动基金 重庆应用基础研究基金资助(2001) 机械工业部跨世纪学术带头人专项基金资助~~
关键词 去乙酰酶抑制剂 4-[N-(吡啶-3-甲氧羰基)氨甲基]苯甲酸 N-(2-氨苯基)-4-[N-(吡啶-3-甲氧羰基)氨甲基]苯甲酰胺 活性酸酐 绿色化学合成 histone deacetylase inhibitors 4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzoic acid N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide active acid anhydride green chemical synthesis
  • 相关文献

参考文献4

  • 1Grunstein M.Histone acetylation in chromatin structure and transcription[J].Nature,1997,389:349—352.
  • 2Yoshida M,Kijima M,Akiut M,et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A[J]. J Biol Chem,1990,265 : 17174 -17179.
  • 3Tsuneji S, Tomoyuki A, Katsutoshi T,et al. Synthesis and histone deacethlase inhibitory activity of new benzamide derivatives[J]. J Meal Chem,1999,42(15) :3001 -3003.
  • 4Silvio M, Antonello M, Gianluca S, et al. 3-(4-Aroyl-1H-pyrrol-2yl )-N-hydroay-2-propenamides, a new class of synthetic histone deacetylase inhibitors[ J]. J M Chem,2001,,44 (13) : 2069 -2072.

同被引文献14

  • 1WITT O, DEUBZER H E, MILDE T, et al. HDAC family:What are the cancer relevant targets? [J].Cancer Lett,2009,277 ( 1 ) : 8 - 21.
  • 2MINUCCI S, PELICCI P G. Histone deacetylase inhibitors and the promise of epigenetic ( and more) treatments for cancer [J ]. Nat Rev Cancer, 2006,6 (1) :38 -51.
  • 3GLASER K B. HDAC inhibitors: clinical update and mechanism-based potential [ J ]. Biochem Pharmacol, 2007,74 (5) : 659 - 671.
  • 4BORTUGNO O A, SANTORO F, MINUCCI S. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer [ J ]. Cancer Lett ,2009,280 ( 2 ) : 134 - 144.
  • 5PARIS M, PORCELLONI M, BINASCHI M, et al. Histone deacetylase inhibitors: from bench to clinic [ J]. J Med Chem ,2008,51 (6) : 1505 - 1529.
  • 6BERTRAND P. Inside HDAC with HDAC inhibitors [ J ]. Eur J Med Chem, 2010,45 ( 6 ) : 2095 - 2116.
  • 7MULDER G J, MEERMAN J H. Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids : the role of N, O-sulfonation in chemical carcinogenesis of aromatic amines J]. Environ Health Perspect, 1983,49:27 - 32.
  • 8ATTENNI B, ONTORIA J M, CRUZ J C, et al. Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model[ J ]. Bioorg Med Chem Lett, 2009,19 (11 ): 3081 - 3084.
  • 9SUZUKI T, ANDO T, TSUCHIYA K, et al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives [J].J Med Chem, 1999,42( 15 ) :3001 - 3003.
  • 10HESS-STUMPP H, BRACKER T U, HENDERSON D, et al. MS-275, a potent orally available inhibitor of histone deacetylases--The development of an anticancer agent[J ]. Int J Biochem Cell Biol, 2007,39 (7/8) : 1388 - 1405.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部